Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
出版年份 2023 全文链接
标题
Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 5, Pages 4646
出版商
MDPI AG
发表日期
2023-02-28
DOI
10.3390/ijms24054646
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides
- (2023) So Hee Nam et al. ARCHIVES OF PHARMACAL RESEARCH
- Peptide Drug Conjugates and Their Role in Cancer Therapy
- (2023) Ethan Heh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Three-dimensional cell cultures as preclinical models to assess the biological activity of phytochemicals in breast cancer
- (2023) Nádia Calvo Martins Okuyama et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The development of peptide-drug conjugates (PDCs) strategies for paclitaxel
- (2022) Longkun Wang et al. Expert Opinion on Drug Delivery
- Emerging nanomedicines of paclitaxel for cancer treatment
- (2022) Qin Chen et al. JOURNAL OF CONTROLLED RELEASE
- Paclitaxel Drug Delivery Systems: Focus on Nanocrystals’ Surface Modifications
- (2022) Razan Haddad et al. Polymers
- Peptide-Drug Conjugates: A New Hope for Cancer Management
- (2022) Vivek P. Chavda et al. MOLECULES
- Emerging nanomedicines strategies focused on tumor microenvironment against cancer recurrence and metastasis
- (2022) Yi Feng et al. CHEMICAL ENGINEERING JOURNAL
- Albumin-based nanodevices for breast cancer diagnosis and therapy
- (2022) Yue Wang et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
- (2022) Mo Wu et al. Experimental Hematology & Oncology
- Peptide–Drug Conjugates with Different Linkers for Cancer Therapy
- (2021) Mona Alas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma
- (2021) Lin Zhao et al. LIFE SCIENCES
- The miR-124-3p/Neuropilin-1 Axis Contributes to the Proliferation and Metastasis of Triple-Negative Breast Cancer Cells and Co-Activates the TGF-β Pathway
- (2021) Jiayang Zhang et al. Frontiers in Oncology
- Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxel
- (2021) Christina M. Scribano et al. Science Translational Medicine
- Pathology of triple negative breast cancer
- (2020) Filippo Borri et al. SEMINARS IN CANCER BIOLOGY
- Progress in systemic therapy for triple-negative breast cancer
- (2020) Hongnan Mo et al. Frontiers of Medicine
- Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
- (2020) Paul Hoppenz et al. Frontiers in Chemistry
- The dawn of targeted therapies for triple negative breast cancer (TNBC): a snapshot of investigational drugs in phase I and II trials
- (2020) My-my Huynh et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies
- (2020) Lin Zhao et al. JOURNAL OF DRUG TARGETING
- Triple-negative breast cancer: new treatment strategies in the era of precision medicine
- (2020) Song-Yang Wu et al. Science China-Life Sciences
- Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
- (2020) Gagan K. Gupta et al. Cancers
- Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?
- (2020) Xupeng Bai et al. CANCER LETTERS
- Advances in Therapeutic Approaches for Triple Negative Breast Cancer
- (2020) Reshma Mahtani et al. Clinical Breast Cancer
- Peptide-functionalized delivery vehicles for enhanced cancer therapy
- (2020) Si-Yue Tang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation
- (2020) Junjie Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Compressive Review about Taxol®: History and Future Challenges
- (2020) Julia Gallego-Jara et al. MOLECULES
- Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell‐Penetrative MMP‐2‐Cleavable Peptide
- (2020) Dan Hua et al. Advanced Science
- Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment
- (2020) Xin Deng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent therapeutic trends and promising targets in triple negative breast cancer
- (2019) Soo-Yeon Hwang et al. PHARMACOLOGY & THERAPEUTICS
- The Functions and Applications of A7R in Anti-angiogenic Therapy, Imaging and Drug Delivery Systems
- (2019) Lu Lu et al. Asian Journal of Pharmaceutical Sciences
- Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
- (2019) Quan Zhou et al. Nature Nanotechnology
- Targeted Therapies for Triple-Negative Breast Cancer
- (2019) Tomas G. Lyons CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Transcytosis of Nanomedicine for Tumor Penetration
- (2019) Yan Liu et al. NANO LETTERS
- Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer
- (2019) Yu Zhou et al. Acta Pharmaceutica Sinica B
- A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer
- (2019) María Victoria Cano-Cortes et al. Nanomedicine-Nanotechnology Biology and Medicine
- Taxol®: The First Microtubule Stabilizing Agent
- (2017) Chia-Ping Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paclitaxel: What has been done and the challenges remain ahead
- (2017) Ezequiel Bernabeu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
- (2017) Shama Dissanayake et al. JOURNAL OF CONTROLLED RELEASE
- Neuropilin-1 Associated Molecules in the Blood Distinguish Poor Prognosis Breast Cancer: A Cross-Sectional Study
- (2017) Adviti Naik et al. Scientific Reports
- Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis
- (2016) Chenxi Hu et al. Targeted Oncology
- Tumor-Targeted Paclitaxel Delivery and Enhanced Penetration Using TAT-Decorated Liposomes Comprising Redox-Responsive Poly(Ethylene Glycol)
- (2015) Han Fu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now